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Abstract
Background: The current knowledge of genes and proteins comes from 'naturally designed'
coding and non-coding regions. It would be interesting to move beyond natural boundaries and
make user-defined parts. To explore this possibility we made six non-natural proteins in E. coli. We
also studied their potential tertiary structure and phenotypic outcomes.
Results: The chosen intergenic sequences were amplified and expressed using pBAD 202/D-
TOPO vector. All six proteins showed significantly low similarity to the known proteins in the
NCBI protein database. The protein expression was confirmed through Western blot. The
endogenous expression of one of the proteins resulted in the cell growth inhibition. The growth
inhibition was completely rescued by culturing cells in the inducer-free medium. Computational
structure prediction suggests globular tertiary structure for two of the six non-natural proteins
synthesized.
Conclusion: To our best knowledge, this is the first study that demonstrates artificial synthesis of
non-natural proteins from existing genomic template, their potential tertiary structure and
phenotypic outcome. The work presented in this paper opens up a new avenue of investigating
fundamental biology. Our approach can also be used to synthesize large numbers of non-natural
RNA and protein parts for useful applications.
Background
Organisms use Nature's inventory of materials and
designs for living. The raw material mostly comes in the
form of DNA, RNA and protein. DNA, a repository for
long-term storage of genetic instructions, comprises of
genes and intergenic regions. While genic regions have
been thoroughly investigated in the past, intergenic
regions have received increased attention recently [1-4]. It
would be interesting to mine intergenic regions for uni-
dentified genes and also use them for making novel pro-
teins.
Here we present a simple and scalable approach of mak-
ing non-natural proteins from the 'not-coding' intergenic
regions. The term 'not-coding' has been used in the con-
text of not-naturally-designed for making proteins. As
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against the previously described approaches of chemically
synthesizing randomized protein sequences [5,6] adding
tolerated point mutations to natural proteins [7], generat-
ing polypeptide sequences by combinatorial shuffling [8],
improving protein functions through directed evolution
[9] we used the existing genomic template of E. coli to
make non-natural proteins.
As a first step, six unique intergenic regions (> 100 bases
in length), with no history of transcription, were ran-
domly selected (Table 1). Of the six samples, five came
from non-overlapping intergenic regions (Fig 1). One
more sequence overlapping with a coding region was
deliberately added to explore the general applicability of
our method. Following criteria were adopted for selecting
genome sequences: (a) the not-coding feature of
sequences based on the absence of complete similarity
with known proteins (b) sequences of different sizes and
orientations. All the sequences were cloned using pBAD
vector and expressed after transfection into E. coli. Expres-
sion was confirmed using western blot. The non-natural
proteins were called eka, meaning 'first' in sanskrit. Cell
growth and shape were used as convenient phenotypic
indicators to study the effect of their intracellular expres-
sion. Standard computational methods were used to pre-
dict potential structures of the proteins synthesized.
eka neighbourhood Figure 1
eka neighbourhood. The nearest neighbourhood scan of the eka sequences. All the sequences are in the intergenic region 
with the exception of eka2 that shows 32% sequence overlap with araC gene.Journal of Biological Engineering 2009, 3:2 http://www.jbioleng.org/content/3/1/2
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Table 1: Description of eka sequences
ID Length a Start – End Overlap Vector sequence Total a+b+c % vector 
contribution
Protein e-value Bit score GC ratio
bc Aa M.W. (i) (ii)
eka1 104 70,283 – 70,386 No 381 157 642 83.8 214 23.5 >10 * 39.4 50.0
eka2 138 3,651,282 – 
3,651,704
Yes, 32% 381 90 609 77.3 203 22.1 > 10 * 42.0 48.3
eka3 432 348,779 – 
349,210
No 381 90 903 52.1 301 33.7 6 e-04 46.2 47.0 48.6
eka4 105 49,681 – 49,785 No 381 90 576 81.7 192 20.9 >10 * 49.5 50.0
eka5 141 57,173 – 57,313 No 381 90 612 76.9 204 22.2 > 10 * 43.2 50.8
eka6 96 70,285 – 70,380 No 381 90 567 83.1 189 20.5 >10 * 39.6 48.3
Start-end indicates genomic location of the selected sequences. 'a' indicates the length of the original genomic insert, 'b' and 'c' indicate vector 
contributed prefix and suffix DNA sequences respectively. Total (a+b+c) indicates the entire DNA sequence expressed into proteins. The pBAD 
vector contribution to the final protein sequence is indicated in percentages. Aa indicates the number of amino acid residues of the synthesized 
protein. M.W. refers to the Isotopically Averaged Molecular Weight calculated in kiloDaltons (kDa). (i) indicates GC ratio of the genomic insert, 
and (ii) indicates GC ratio of the complete DNA sequence (vector + genomic DNA) expressed into proteins. The large e-value and extremely small 
bit score approaching zero (*) indicates very low sequence similarity of eka proteins to the known protein sequences.
western blot Figure 2
western blot. The western blot of (a) EKA 1-EKA 3, (b) EKA 4 – EKA 6 proteins. See ref. [26] and the method section for 
details. The – sign indicates the negative control and + sign indicates induced expression of EKA protein.Journal of Biological Engineering 2009, 3:2 http://www.jbioleng.org/content/3/1/2
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Results and discussion
The natural non-protein-coding property of eka sequences
was confirmed by sequence similarity comparisons using
BLASTP against the non-redundant protein database of
NCBI. The entire full-length EKA sequences did not fully
resemble any known naturally occurring proteins (Table
1). Amplified sequences and enzyme digests of the recom-
binant pBAD vector matched expected molecular weights.
The presence and correct orientation of eka sequences (in
the pBAD vector) was confirmed by sequencing and gel
electrophoresis. The overall length of the protein
sequences was found to be longer than the expected. This
was due to contribution from the pBAD vector to the final
protein sequences (Table 1). The Western blot (Fig 2) con-
firmed expression of EKA 1–6 proteins. Of six proteins
expressed intracellularly, EKA1 showed significant growth
inhibitory effects whereas EKA2 – EKA6 expression did
not impact the cell growth (Fig 3). We do not yet know the
effect of prefix and suffix sequences on the physiological
behavior or folding pattern of the final protein sequences.
It is interesting to note a shift in the GC content from 39.4
– 49.5 (original genomic insert) to 48.3 – 50.8 (after
insertion into the vector). It is not known if the shift in GC
content is one of the reasons for eka protein expression in
E. coli with an average GC content of 50.8% [10]. A future
step will be producing proteins without prefix and suffix
sequences and compare folding pattern and phenotypes.
Of six sequences only two i.e., EKA3 and EKA5, produced
results that could be interpreted as being partially compat-
ible with forming a tertiary structure. In the resulting four
models of EKA3: 1ub3 [11], 1mzh [Tan AY, Smith PC;
Crystal Structure of Aquifex Aeolicus Aldolase, Unpub-
lished] 2dxn [12], 2hy1 [13]. (Fig 4a), we observed a
recurring consensus pattern of alternating helix and beta
strand that assembles into a larger structure with a com-
cell growth Figure 3
cell growth. The growth-plot of the wild type (WT) and transformed E. coli cells (Eka1-Eka6). A tiny nick at the AraB+/AraB- 
boundary indicates loss of eka3 transformed cells at the wash step.Journal of Biological Engineering 2009, 3:2 http://www.jbioleng.org/content/3/1/2
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bined beta sheet on one side and the packed helices on the
other. The difference in the width of the beta strands and
helices imposes a curvature on the structure leaving the
beta sheet in the concave inside and the helices in the con-
vex outside. While in the representative template Aldolase
(PDB:1mzh) this pattern leads to full closure of the beta
sheet into a beta barrel, EKA3 has less repeating units and,
hence, covers approximately half of the full template
structure. Though the helical outside surface of our mod-
els consists of mainly hydrophilic residues pointing into
the solvent, there are some hydrophobic residues in the
beta sheets pointing to the inside of the half beta barrel,
which may be partially exposed to solvent and hence
could cause problems for folding of this structure.
In EKA5 (Fig 4b), weak similarity to the beta propeller
fold of viral neuroaminidases was suggested by using the
PDB-Basic tool from the 3D-Jury authors [14]. When
modelling EKA5 onto the 2 predicted templates (PDB:
2htv and 2ht5, [15] using Modeller [16], it becomes
apparent that the aligned portion of EKA5 only covers 3
out of 4 beta strands that would normally form a beta
sheet representing one of six blades of the overall propel-
ler structure (Fig 4b). Correct folding depends on proper
stacking of the blades including hydrophobic contacts
that would indicate that a single blade alone, as predicted
for EKA5, would not form a stable structure. An interest-
ing question is whether EKA5 single blades could eventu-
ally homo-polymerize into a full propeller, when over-
expressed. However, such speculations can only be
answered through further experimental structural studies.
Most of the currently known protein functions require
folding of a protein sequence into a globular structure.
Hence, we wanted to investigate if the sequences could
principally adopt a known fold. While pure ab initio struc-
ture prediction is still in its infancy, the most successful
current methods strongly rely on sequence similarity for
fold recognition. However, we are dealing with new
unknown sequences not expected to have clear homo-
logues. Our method of choice was to try several possibili-
ties and take a consensus of the predictions [17]. Notably,
threading methods gave more consistent results (more
template hits were similar to each other), which makes
sense since threading methods emphasize more on com-
pliance with the biophysical needs of a sequence fitting
into the structure rather than depending on similarity to
sequences of known structures. Only for the longest of the
6 sequence inserts, EKA3 (143 amino acids), a globular
tertiary structure was predicted. EKA5 (47 amino acids)
tructural models of proteins Figure 4
tructural models of proteins. (a) Structural models of the EKA3 protein based on the PDB templates in order of their 
ranking by 3D-Jury: (a1) 1ub3 (a2) 1mzh (a3) 2dxn and (a4) 2hy1. (b) Structural models of the EKA5 protein based on the PDB 
templates 2htv (lila) and 2ht5 (blue). Left side: The two structural models in the context of the full structure of their templates 
2htv (yellow) and 2ht5 (green).Journal of Biological Engineering 2009, 3:2 http://www.jbioleng.org/content/3/1/2
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also showed similarity to a known fold, however, only to
one of its substructures not known to form a stable struc-
ture on its own. Similarly, the other four, EKA1 (33 amino
acids), EKA2 (46 amino acids), EKA4 (35 amino acids)
and EKA6 (32 amino acids) appear too short to form com-
plex tertiary structures on their own. At best we find simi-
larities to not more than a single helix. Furthermore, low
complexity predictions [18] over large parts of their
sequence are an additional indicator of absence of globu-
lar structure. On the other hand, the proposed structure
for EKA3 is consistent among the models derived from the
4 top-ranked hits, adding support to the prediction, and
the inter-model variability (Fig 4a) allows estimating the
maximal accuracy that can be expected in this case. How-
ever, structure predictions in the absence of sequence sim-
ilarity remain notoriously difficult at this time and
experimental validation is needed to confirm validity of
our models.
We do not disregard the possibility that some of the EKA
genes may turn out to be real in some organisms or may
represent evolutionary remnants of what-was-once a func-
tional sequence. In fact, in one of the previous studies,
expression for 4052 coding transcripts and 1102 addi-
tional transcripts in the intergenic regions of the E. coli
genome was identified using the whole genome array
[19]. However, intentional conversion of these sequences
to synthesize non-natural proteins is a novel attempt, to
our best knowledge. One could ask why Nature didn't
sample these genomic regions? And if Nature indeed sam-
pled these regions – were these proteins discarded? If yes,
why? To answer such questions one must synthesize more
non-natural proteins and study their impact on cell phys-
iology. It would be interesting to sample conserved inter-
genic regions, subsets of introns, overlapping regions, and
so on and study the impact of making novel RNA and pro-
tein parts. Given that 98.5% of human genome is made of
intergenic regions, it would be useful to mine this enor-
mous resource to make non-natural parts for useful appli-
cations. It has not escaped our attention that our approach
can be extended to make non-natural RNA parts, both
coding and non-coding.
Interestingly, several studies point to the evolution-driven
conversion of not-coding regions to coding regions [20-
24]. However, our work demonstrates a user-defined con-
version leading to the synthesis of non-natural parts. It
would be relevant to ask: how to evaluate functions of
genes 'not naturally needed for survival'. The traditional
approaches of gene knockout and down-regulation of
expression are unattractive since organisms don't need
these parts by default. In our opinion, expressing such
sequences under the control of a strong promoter, fol-
lowed by microarray analysis could help identify interac-
tions and pathways through which such non-natural parts
act.
Furthermore, non-natural proteins that are stably
expressed can be systematically tested if they adopt new
folds or functions of any kinds. Besides looking at these
non-natural proteins in isolation, different effects could
possibly be obtained by combining them with known
domains. In theory, it could be possible to derive novel
synthetic multi-domain proteins in a combinatorial fash-
ion. Given that our analyzed examples indicate both non-
coding intergenic and coding but out-of-frame segments
as suitable candidates for producing variants of new pro-
teins, the imaginable number of potential new RNA and
protein parts and their combinations is enormous.
It is worth noting that our work does not describe an
approach for rationally designing RNA and proteins parts
based on higher-level parameters. Our approach resem-
bles a semi-random strategy of synthesizing non-natural
parts, followed by functional analysis. Although we were
successful in expressing all the six sequences, we do not
know the boundary conditions of this approach, if any. To
answer this question, one should make proteins from
genome regions of different lengths, origins and features.
Conclusion
To the best of our knowledge this is the first report that
describes artificial synthesis of protein parts from
genomic regions not naturally utilized to make proteins.
It would be interesting to extend this study to synthesize
and characterize non-natural RNA parts. The cell-free syn-
thesis of non-natural parts can be used in situations where
their intracellular synthesis results in cell death. The other
important issue, addressed through this work, is the pre-
diction of potential tertiary structures of non-natural pro-
teins. Though initial computational analysis indicates
several potential structures, experimental study is needed
to confirm these predictions. In future, an extensive study
is required to uncover existence of novel structures 'possi-
bly embedded' in the genome. Finally, our approach can
be used to make novel enzymes, transcription factors,
receptor proteins and so on.
Methods
Six eka sequences were chosen on the basis of the absence
of a complete set of promoter, start and stop signals. In
addition to sampling intergenic regions, overlapping
regions of coding and intergenic sequences were also con-
sidered to broaden the scope of the work. From a large
number of possibilities that exist (Fig 5) contiguous
sequences were randomly chosen at an arbitrary cut-off
value of ~100 bases. All the eka sequences (Additional file
1) were computationally translated into amino acid
sequences. These sequences were BLASTed against theJournal of Biological Engineering 2009, 3:2 http://www.jbioleng.org/content/3/1/2
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NCBI NR protein sequence database to find similarity to
known proteins, if any. PSI-BLAST [25] was used at the e-
value cut off 10. The E. coli K12 (MG1655) strain, pro-
vided by the National Institute of Genetics (NIG, Japan),
were grown in the LB growth medium at 37°C. The trans-
formed cells were cultured in kanamycin-supplemented
LB medium (50 μg·ml-1). Genomic DNA was purified by
Wizard® Genomic DNA Purification Kit. PCR amplifica-
tion was performed with the forward and reverse primers
by using the E. coli genome as a template. The PCR prod-
ucts of the sequences were confirmed by gel electrophore-
sis. The overall approach (Fig. 6) essentially comprised
selecting the desired sequence and amplifying and insert-
ing the sequences into a pBAD202/D-TOPO vector (Invit-
rogen). The pBAD vector provided a ready-to-use
template, an inducible promoter, start and stop codons,
for expression of sequences (Fig 7). Inserting eka
sequences downstream of the "promoter and start codon"
and upstream of the stop codon generated coding
sequences. The directional insertion of eka sequences in
the pBAD topo vector was achieved by following the com-
pany's protocol. The presence and orientation of inserts
was confirmed by sequencing and gel electrophoresis. The
recombinant pBAD vector was used for the transforma-
tion of the One Shot®  TOP10 chemically competent
MG1655 E. coli cells by using Invitrogen's standard proto-
col. Colonies were screened on kanamycin (50 μg·ml-1)-
supplemented LB medium. Protein expression in the
transformed MG1655 cells was induced by adding 0.02%
arabinose to the culture medium. The EKA proteins in the
transformed cells were detected by western blotting
(WesternBreeze kit, Invitrogen). The expression of pro-
teins was visualized by western blot according to the
standard protocols [26]. For each sample, 10–20 μl of the
proteins were electrophorsed using 12% SDS PAGE for 70
min at 200 V. Proteins were transferred from gel to poly-
vinyldifluoride (PVDF) membrane for 1 h at 100 V. West-
ern blot was performed using WesternBreeze®
chromogenic western blot immunodetection kit accord-
ing to the manufacturer's protocol. After 1 h blockade of
nonspecific binding sites by blockers, the PVDF mem-
brane was incubated for 15 h at 4°C with a mouse anti-
cleaved Anti-ThioTM antibody (1:20,000) followed by 1 h
incubation with an alkaline phosphatase-conjugated anti-
mouse IgG secondary antibody. Immunoblots were devel-
oped using chromogenic substrate for 10 min and the
membrane was air-dried overnight. The chromogenic sub-
strate was a mixture of BCIP (5-Bromo-4-Chloro-3-
Indolyl phosphate) and NBT (Nitroblue Tetrazolium
Salt). The solution provided by Invitrogen was diluted 8
times with distilled water and then used.
The positive (pBAD/D/lacZ, Invitrogen) and negative con-
trols (i.e. without eka sequences) were used to validate the
expressions of EKA proteins. The pBAD202/D/lacZ vector
was used as a positive control, and the pBAD202/D-
E. coli intergenic regions Figure 5
E. coli intergenic regions. Distribution of the contiguous intergenic regions in E. coli (a) that include stop codons and (b) 
without stop codons. Note an increase in the longer genomic fragments in the sample (a) available for making non-natural pro-
teins.Journal of Biological Engineering 2009, 3:2 http://www.jbioleng.org/content/3/1/2
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TOPO vector without eka sequence was used as a negative
control. Cell growth was automatically monitored every
10 minutes for 10 hours using an automated multiplate
reader (Tecan Plate Reader, Magellan 200) at 37°C. The
growth inhibitory effect of EKA1 was rescued by removing
the inducer i.e., washing and re-culturing cells in arab-
inose (-) medium (Fig 3).
To investigate the possibility of EKA proteins folding into
globular structures, all the six protein sequences were sub-
Overview of the method Figure 6
Overview of the method. General scheme of producing proteins from not-naturally-coding DNA sequences.Journal of Biological Engineering 2009, 3:2 http://www.jbioleng.org/content/3/1/2
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mitted to the consensus structure prediction method, 3D-
Jury [14]. The algorithm identifies consensus structural
units shared among templates suggested by a wide range
of established structure prediction servers. In the case of
EKA3, all 4 top-ranked hits came from predictions by the
threading method mGenThreader [27]. Since these hits
are structurally related, we chose each of them as separate
templates for modeling using the Software Modeller [16]
(version 9.1) to gauge the structural variability of similar
predictions. Figures of the structures were generated using
Yasara application [28].
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